These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15389620)

  • 21. Combining Pharmacotherapy with cognitive-behavioral interventions for obsessive-compulsive disorder.
    Cottraux J; Bouvard MA; Milliery M
    Cogn Behav Ther; 2005; 34(3):185-92. PubMed ID: 16201063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An adolescent male with features of EDNOS and obsessive-compulsive disorder.
    Yanover T; Thompson JK; Straub DM
    Eat Weight Disord; 2008 Jun; 13(2):e20-4. PubMed ID: 18612248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [What is the place of emotion in cognitive-behavioral approaches of obsessive-compulsive disorders?].
    Stankovic M
    Sante Ment Que; 2004; 29(1):105-14. PubMed ID: 15470566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmenting SRIs for Obsessive-Compulsive Disorder: Patient Preference for Risperidone Does Not Limit Effectiveness of Exposure and Ritual Prevention.
    Wheaton MG; Carpenter JK; Kalanthroff E; Foa EB; Simpson HB
    Psychother Psychosom; 2016; 85(5):314-6. PubMed ID: 27513584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of obsessive-compulsive disorder: personal follow-up of a 10-year material from an outpatient county clinic.
    Olsen T; Mais AH; Bilet T; Martinsen EW
    Nord J Psychiatry; 2008; 62(1):39-45. PubMed ID: 18389424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of obsessive-compulsive disorder.
    Marks I
    Br J Psychiatry; 1995 Sep; 167(3):411-2. PubMed ID: 7496662
    [No Abstract]   [Full Text] [Related]  

  • 27. The impact of symptom dimensions on outcome for exposure and ritual prevention therapy in obsessive-compulsive disorder.
    Williams MT; Farris SG; Turkheimer EN; Franklin ME; Simpson HB; Liebowitz M; Foa EB
    J Anxiety Disord; 2014 Aug; 28(6):553-8. PubMed ID: 24983796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obsessive-compulsive disorder: diagnostic and treatment issues.
    Stein DJ; Denys D; Gloster AT; Hollander E; Leckman JF; Rauch SL; Phillips KA
    Psychiatr Clin North Am; 2009 Sep; 32(3):665-85. PubMed ID: 19716996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Change in obsessive-compulsive symptoms mediates subsequent change in depressive symptoms during exposure and response prevention.
    Zandberg LJ; Zang Y; McLean CP; Yeh R; Simpson HB; Foa EB
    Behav Res Ther; 2015 May; 68():76-81. PubMed ID: 25824533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exposure with response prevention and serotonergic antidepressants in the treatment of obsessive compulsive disorder: a review and implications for interdisciplinary treatment.
    Abel JL
    Behav Res Ther; 1993 Jun; 31(5):463-78. PubMed ID: 8101439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive therapy with obsessive-compulsive disorder: a comparative evaluation.
    Emmelkamp PM; Beens H
    Behav Res Ther; 1991; 29(3):293-300. PubMed ID: 1679324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Processes of change in cognitive-behavioural treatment of obsessive-compulsive disorder: Current status and some future directions.
    Polman A; Bouman TK; van Hout WJ; de Jong PJ; den Boer JA
    Clin Psychol Psychother; 2010; 17(1):1-12. PubMed ID: 19658125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Obsessive-compulsive disorder in children and adolescents].
    Jans T; Walitza S; Warnke A
    Prax Kinderpsychol Kinderpsychiatr; 2008; 57(6):429-56. PubMed ID: 18800672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive-behavioral treatment of repugnant obsessions.
    Purdon C
    J Clin Psychol; 2004 Nov; 60(11):1169-80. PubMed ID: 15389619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I).
    Garcia AM; Sapyta JJ; Moore PS; Freeman JB; Franklin ME; March JS; Foa EB
    J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1024-33; quiz 1086. PubMed ID: 20855047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of axis I and II comorbidity on behavior therapy outcome for obsessive-compulsive disorder and agoraphobia.
    Steketee G; Chambless DL; Tran GQ
    Compr Psychiatry; 2001; 42(1):76-86. PubMed ID: 11154720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EEG-arousal regulation as predictor of treatment response in patients suffering from obsessive compulsive disorder.
    Dohrmann AL; Stengler K; Jahn I; Olbrich S
    Clin Neurophysiol; 2017 Oct; 128(10):1906-1914. PubMed ID: 28826021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Psychotherapy of compulsive disorder in children and adolescents--an overview].
    Simons M; Herpertz-Dahlmann B
    Z Kinder Jugendpsychiatr Psychother; 2003 Aug; 31(3):213-21. PubMed ID: 12942793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of treatment outcome in modular cognitive therapy for obsessive-compulsive disorder.
    Steketee G; Siev J; Fama JM; Keshaviah A; Chosak A; Wilhelm S
    Depress Anxiety; 2011 Apr; 28(4):333-41. PubMed ID: 21308884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective relationship between obsessive-compulsive and depressive symptoms during multimodal treatment in pediatric obsessive-compulsive disorder.
    Meyer JM; McNamara JP; Reid AM; Storch EA; Geffken GR; Mason DM; Murphy TK; Bussing R
    Child Psychiatry Hum Dev; 2014; 45(2):163-72. PubMed ID: 23756717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.